Results 31 to 40 of about 9,100 (154)
Alimentary Pharmacology &Therapeutics, EarlyView.In 902 patients with HBV‐related HCC undergoing curative resection, antiviral regimens (ETV, TDF, TAF) showed comparable recurrence‐free survival. However, TDF was independently associated with improved overall survival compared with ETV. ABSTRACT Background & Aims The comparative outcomes of entecavir (ETV), tenofovir disoproxil fumarate (TDF), and ...
Jaehong Jeong +10 more
wiley +1 more source
Frontiers in PharmacologyObjectivesTo systematically evaluate the efficacy and safety of tenofovir and entecavir in chronic hepatitis B-related cirrhosis.MethodsA comprehensive search was conducted in databases including PubMed, Web of Science, Embase and Cochrane Library from ...
Lu Cao +4 more
doaj +1 more source
Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B
Annals of Hepatology, 2016 Background and aims. CD4+ T cells play an important role in response to hepatitis B virus (HBV) infection. We investigated the change in CD4+ T-cell subpopulations and viral load in patients with chronic HBV infection who were treated with entecavir ...
Tian Zhan-Fei +4 more
doaj +1 more source
Extended Double Plasma Molecular Adsorption Sessions and Bilirubin Clearance: A Case Report
Hemodialysis International, EarlyView.ABSTRACT Background The double plasma molecular adsorption system is an artificial‐liver treatment model combining the use of ion exchange resins and neutral microporous resins to remove toxins such as inflammatory cytokines without consuming large amounts of plasma and albumin. Given the relatively expensive consumables needed for Bilirubin adsorption,
Hui Ye +7 more
wiley +1 more source
Auxiliary Liver Graft Can Be Protected From HBV Infection in HBsAg Positive Blood Circulation
Frontiers in Medicine, 2021 Auxiliary grafts have a high risk of Hepatitis B virus (HBV) infection in patients with chronic HBV-related diseases. Hepatitis B virus-related auxiliary partial orthotopic liver transplantation (APOLT) cases were reviewed to show the results of current ...
Lin Wei +22 more
doaj +1 more source
Journal of Gastroenterology and Hepatology, EarlyView.ABSTRACT Background Chronic hepatitis B virus (HBV) remains a major cause of hepatocellular carcinoma (HCC) in Australia, despite the availability of effective, subsidized antiviral therapy. We aimed to describe the clinical characteristics, HBV care cascade, and outcomes among people with HBV‐related HCC in Victoria, Australia.
Dina Moussa +23 more
wiley +1 more source
Journal of Viral Hepatitis, Volume 33, Issue 9, September 2026.ABSTRACT As little is known about the disease burden of chronic hepatitis D virus (HDV) infection, this study examined health‐related quality of life (HRQoL) and fatigue at different disease stages. This was a real‐world quantitative cross‐sectional survey of patients in Germany, Italy, Spain and the USA.
P. Lampertico +11 more
wiley +1 more source
Release mechanism and pharmacodynamics of entecavir micro spheres
Pakistan Journal of Pharmaceutical SciencesEntecavir, an effective anti-hepatitis B drug with low resistance rate, was designed as sustained-release micro spheres in our previous study. Here, we aimed to reveal the drug-release mechanism by observing the drug distribution and degradation behavior
Chunyan Zhang +3 more
doaj +1 more source
Journal of the Formosan Medical Association, 2014 Several anti-viral drugs are approved for the treatment of hepatitis B virus (HBV) infection. However, whether quantitative hepatitis B surface antigen (qHBsAg) can predict the therapeutic response during long-term entecavir treatment remains unclear ...
Chia-Chi Wang +4 more
doaj +1 more source
Characterising Hepatitis D Virus in the UK From 2011 to 2021
Journal of Viral Hepatitis, Volume 33, Issue 9, September 2026.ABSTRACT Little is known about hepatitis B virus (HBV) and Hepatitis D virus (HDV) coinfection in the UK. HDV screening is recommended among all individuals with HBV, with coinfection associated with increased disease progression. Using data on HDV testing, shared by 11 laboratories in the UK who reported undertaking HDV testing, and national testing ...
R. Simmons +67 more
wiley +1 more source